These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2516176)

  • 1. Neurological deterioration in adult phenylketonuria.
    Villasana D; Butler IJ; Williams JC; Roongta SM
    J Inherit Metab Dis; 1989; 12(4):451-7. PubMed ID: 2516176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hyperphenylalaninaemia presumably caused by a new variant of biopterin synthetase deficiency.
    Dhondt JL; Guibaud P; Rolland MO; Dorche C; Andre S; Forzy G; Hayte JM
    Eur J Pediatr; 1988 Feb; 147(2):153-7. PubMed ID: 3366132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved identification of heterozygotes for phenylketonuria using blood neopterin and biopterin.
    Alós T; Bel Y; Cabello ML; Catalá JL; Dalmau J; Ferré J; García AM; Ruiz-Vázquez P
    J Inherit Metab Dis; 1993; 16(2):457-64. PubMed ID: 8412006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphenylalaninaemia caused by defects in biopterin metabolism.
    Kaufman S
    J Inherit Metab Dis; 1985; 8 Suppl 1():20-7. PubMed ID: 3930837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.
    Pilotto A; Blau N; Leks E; Schulte C; Deuschl C; Zipser C; Piel D; Freisinger P; Gramer G; Kölker S; Haas D; Burgard P; Nawroth P; Georg H; Scheffler K; Berg D; Trefz F
    J Inherit Metab Dis; 2019 May; 42(3):398-406. PubMed ID: 30706953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain MRI changes in phenylketonuria. Associations with dietary status.
    Thompson AJ; Tillotson S; Smith I; Kendall B; Moore SG; Brenton DP
    Brain; 1993 Aug; 116 ( Pt 4)():811-21. PubMed ID: 8353710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin and biopterin levels in patients with atypical forms of phenylketonuria.
    Nixon JC; Lee CL; Milstien S; Kaufman S; Bartholomé K
    J Neurochem; 1980 Oct; 35(4):898-904. PubMed ID: 7452296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delusional disorder in a boy with phenylketonuria and amine metabolites in the cerebrospinal fluid after treatment with neuroleptics.
    Shiwach RS; Sheikha S
    J Adolesc Health; 1998 Mar; 22(3):244-6. PubMed ID: 9502013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.
    Kaufman S; Kapatos G; Rizzo WB; Schulman JD; Tamarkin L; Van Loon GR
    Ann Neurol; 1983 Sep; 14(3):308-15. PubMed ID: 6139056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive convulsive encephalopathy: considering a abnormality of biopterin metabolism].
    Mikaeloff Y; Pinton F; Sevin C; Dhondt JL; Ponsot G
    Arch Pediatr; 1999 Jul; 6(7):759-61. PubMed ID: 10429818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatable neurotransmitter deficiency in mild phenylketonuria.
    Bonafé L; Blau N; Burlina AP; Romstad A; Güttler F; Burlina AB
    Neurology; 2001 Sep; 57(5):908-11. PubMed ID: 11552030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of phenylketonuria.
    Shaw DW; Maravilla KR; Weinberger E; Garretson J; Trahms CM; Scott CR
    AJNR Am J Neuroradiol; 1991; 12(3):403-6. PubMed ID: 2058482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.
    Butler IJ; O'Flynn ME; Seifert WE; Howell RR
    J Pediatr; 1981 May; 98(5):729-33. PubMed ID: 6112253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult phenylketonuria presenting with subacute severe neurologic symptoms.
    Seki M; Takizawa T; Suzuki S; Shimizu T; Shibata H; Ishii T; Hasegawa T; Suzuki N
    J Clin Neurosci; 2015 Aug; 22(8):1361-3. PubMed ID: 25913748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin and dietary restriction in mild phenylketonuria.
    Seashore MR
    N Engl J Med; 2002 Dec; 347(26):2094-5. PubMed ID: 12501220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.